DaVita's board approved a $2 billion increase to its share repurchase program on September 5, 2024. The new authorization complements the existing program from December 2021, with no expiration date. Repurchases may occur through open market transactions, private negotiations, or the existing agreement with Berkshire Hathaway Inc.The board also adopted amended and restated bylaws, effective immediately. Key changes include revised procedures for stockholder nominations of directors, updated meeting procedures, clarified Board Chair powers, and confirmation of CEO authority to appoint Company Officers. The company maintains flexibility in the timing and execution of share repurchases, subject to market conditions and credit facility limitations.

DaVita's board approved a $2 billion increase to its share repurchase program on September 5, 2024. The new authorization complements the existing program from December 2021, with no expiration date. Repurchases may occur through open market transactions, private negotiations, or the existing agreement with Berkshire Hathaway Inc.The board also adopted amended and restated bylaws, effective immediately. Key changes include revised procedures for stockholder nominations of directors, updated meeting procedures, clarified Board Chair powers, and confirmation of CEO authority to appoint Company Officers. The company maintains flexibility in the timing and execution of share repurchases, subject to market conditions and credit facility limitations.